These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 2379149

  • 1. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
    Koga M, Musgrove EA, Sutherland RL.
    Cancer Res; 1990 Aug 15; 50(16):4849-55. PubMed ID: 2379149
    [Abstract] [Full Text] [Related]

  • 2. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR, Murphy LC, Hall RE, Sutherland RL.
    Cancer Res; 1985 Apr 15; 45(4):1525-31. PubMed ID: 3978620
    [Abstract] [Full Text] [Related]

  • 3. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
    Koga M, Eisman JA, Sutherland RL.
    Cancer Res; 1988 May 15; 48(10):2734-9. PubMed ID: 2834048
    [Abstract] [Full Text] [Related]

  • 4. Phorbol ester and epidermal growth factor receptors in human breast cancer.
    Wyss R, Fabbro D, Regazzi R, Borner C, Takahashi A, Eppenberger U.
    Anticancer Res; 1987 May 15; 7(4B):721-7. PubMed ID: 3499860
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture.
    Imai Y, Leung CK, Friesen HG, Shiu RP.
    Cancer Res; 1982 Nov 15; 42(11):4394-8. PubMed ID: 6290036
    [Abstract] [Full Text] [Related]

  • 6. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
    Colburn NH, Gindhart TD, Hegamyer GA, Blumberg PM, Delclos KB, Magun BE, Lockyer J.
    Cancer Res; 1982 Aug 15; 42(8):3093-7. PubMed ID: 6284358
    [Abstract] [Full Text] [Related]

  • 7. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.
    Fitzpatrick SL, LaChance MP, Schultz GS.
    Cancer Res; 1984 Aug 15; 44(8):3442-7. PubMed ID: 6331647
    [Abstract] [Full Text] [Related]

  • 8. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR, Sutherland RL.
    Cancer Res; 1987 Oct 15; 47(20):5323-9. PubMed ID: 3652038
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship.
    Fabbro D, Küng W, Roos W, Regazzi R, Eppenberger U.
    Cancer Res; 1986 Jun 15; 46(6):2720-5. PubMed ID: 3008998
    [Abstract] [Full Text] [Related]

  • 10. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
    Sutherland RL, Hall RE, Pang GY, Musgrove EA, Clarke CL.
    Cancer Res; 1988 Sep 15; 48(18):5084-91. PubMed ID: 2970295
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schultz GS.
    Cancer Res; 1984 Aug 15; 44(8):3448-53. PubMed ID: 6331648
    [Abstract] [Full Text] [Related]

  • 12. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
    Reddel RR, Alexander IE, Koga M, Shine J, Sutherland RL.
    Cancer Res; 1988 Aug 01; 48(15):4340-7. PubMed ID: 3390830
    [Abstract] [Full Text] [Related]

  • 13. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.
    Murphy LJ, Sutherland RL, Stead B, Murphy LC, Lazarus L.
    Cancer Res; 1986 Feb 01; 46(2):728-34. PubMed ID: 3000583
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
    Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A, Osborne CK.
    Cancer Res; 1992 Jul 01; 52(13):3636-41. PubMed ID: 1617636
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK.
    Cancer Res; 1988 Jul 15; 48(14):3898-904. PubMed ID: 3164252
    [Abstract] [Full Text] [Related]

  • 16. Effect of epidermal growth factor on the proliferation of human epithelial cancer cell lines: correlation with the level of occupied EGF receptor.
    Dong XF, Berthois Y, Martin PM.
    Anticancer Res; 1991 Jul 15; 11(2):737-43. PubMed ID: 2064328
    [Abstract] [Full Text] [Related]

  • 17. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
    Kosano H, Takatani O.
    Cancer Res; 1988 Nov 01; 48(21):6033-6. PubMed ID: 3262419
    [Abstract] [Full Text] [Related]

  • 18. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
    Murphy LJ, Murphy LC, Vrhovsek E, Sutherland RL, Lazarus L.
    Cancer Res; 1984 May 01; 44(5):1963-8. PubMed ID: 6324992
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR, Bradley SV, Fuchshuber S, Conover CA.
    Gynecol Oncol; 2004 Sep 01; 94(3):705-12. PubMed ID: 15350362
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
    Kennedy MJ, Prestigiacomo LJ, Tyler G, May WS, Davidson NE.
    Cancer Res; 1992 Mar 01; 52(5):1278-83. PubMed ID: 1737390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.